Fast Locator 2012-2013: Covance - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Fast Locator 2012-2013: Covance


Covance Outsourcing Services

Year Founded:

1997

Regions where services are provided:

North America, Asia, Europe.

Number of Employees:

501+

Annual Revenues:

$500 million+

Outsourcing services provided:

Analytical Services

  • Bioanalytical testing
  • Chemistry & stability
  • Microbiology
  • Particle characterization
  • Product characterization

Consulting Services

  • Regulatory, Validation, IT, & QA/QC Services

Development and Phase I/II CTM

  • API–small molecule

API Production Technologies

  • Acetylenic chemistry
  • Acylation
  • Amidation
  • Amino acids and analogs
  • Asymmetric synthesis or chiral chemistry
  • Cyanide chemistry
  • Nitration
  • Organometallic chemistry
  • Sulfonation

Website:

www.covance.com

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here